{"id":46075,"date":"2024-05-27T17:22:46","date_gmt":"2024-05-27T15:22:46","guid":{"rendered":"https:\/\/capitalmind.com\/?post_type=deals&#038;p=46075"},"modified":"2024-06-06T14:58:57","modified_gmt":"2024-06-06T12:58:57","slug":"cession-dortholab-a-excent-tandtechniek-oakley-capital","status":"publish","type":"deals","link":"https:\/\/dev2.capitalmind.com\/fr\/deals\/cession-dortholab-a-excent-tandtechniek-oakley-capital\/","title":{"rendered":"Cession d&rsquo;Ortholab \u00e0 Excent Tandtechniek (Oakley Capital)"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Investec a conseill\u00e9 l&rsquo;actionnaire d&rsquo;Ortholab dans le cadre de la cession \u00e0 100% \u00e0 Excent Tandtechniek, soutenue par Oakley Capital.<\/strong><\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-a-propos-du-deal\">A propos du deal<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Ortholab, cr\u00e9\u00e9 en 1967, est un groupe de laboratoires d&rsquo;orthodontie renomm\u00e9s qui fournit des travaux techniques et des services de haute qualit\u00e9 aux orthodontistes. En mettant l&rsquo;accent sur l&rsquo;innovation et l&rsquo;excellence, Ortholab s&rsquo;est forg\u00e9 une solide r\u00e9putation dans le domaine de l&rsquo;orthodontie. Employant des techniciens exp\u00e9riment\u00e9s, l&rsquo;entreprise produit des appareils orthodontiques et des appareils de r\u00e9tention avanc\u00e9s en utilisant des technologies de pointe, y compris l&rsquo;impression 3D, afin d&rsquo;obtenir un alignement pr\u00e9cis des dents.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Roelant Seijger, propri\u00e9taire et directeur d&rsquo;Ortholab, restera responsable du management des laboratoires d&rsquo;orthodontie apr\u00e8s l&rsquo;acquisition.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Avec cette transaction, Excent Tandtechniek poursuit la mise en \u0153uvre de sa strat\u00e9gie de croissance ambitieuse, bas\u00e9e sur une croissance organique, une expansion \u00e0 l&rsquo;international et des fusions-acquisitions cibl\u00e9es.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-notre-role\">Notre r\u00f4le<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Investec a conseill\u00e9 les actionnaires d&rsquo;Ortholab tout au long du processus de vente, avec :<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Gestion des n\u00e9gociations de prix<\/li>\n\n\n\n<li>Gestion de la due diligence<\/li>\n\n\n\n<li>Coordination de la phase de documentation juridique<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Investec a conseill\u00e9 l&rsquo;actionnaire d&rsquo;Ortholab dans le cadre de la cession \u00e0 100% \u00e0 Excent Tandtechniek, soutenue par Oakley Capital&#8230;.<\/p>\n","protected":false},"featured_media":0,"template":"","dt":[16663,16652],"sector":[3768],"dealtype":[16633,3706],"clienttype":[3729],"class_list":["post-46075","deals","type-deals","status-publish","hentry","dt-cession","dt-sante","sector-healthcare-fr","dealtype-mbo-fr","dealtype-cession-fr","clienttype-entrepreneurs-fr"],"acf":[],"_links":{"self":[{"href":"https:\/\/dev2.capitalmind.com\/fr\/wp-json\/wp\/v2\/deals\/46075","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dev2.capitalmind.com\/fr\/wp-json\/wp\/v2\/deals"}],"about":[{"href":"https:\/\/dev2.capitalmind.com\/fr\/wp-json\/wp\/v2\/types\/deals"}],"wp:attachment":[{"href":"https:\/\/dev2.capitalmind.com\/fr\/wp-json\/wp\/v2\/media?parent=46075"}],"wp:term":[{"taxonomy":"dt","embeddable":true,"href":"https:\/\/dev2.capitalmind.com\/fr\/wp-json\/wp\/v2\/dt?post=46075"},{"taxonomy":"sector","embeddable":true,"href":"https:\/\/dev2.capitalmind.com\/fr\/wp-json\/wp\/v2\/sector?post=46075"},{"taxonomy":"dealtype","embeddable":true,"href":"https:\/\/dev2.capitalmind.com\/fr\/wp-json\/wp\/v2\/dealtype?post=46075"},{"taxonomy":"clienttype","embeddable":true,"href":"https:\/\/dev2.capitalmind.com\/fr\/wp-json\/wp\/v2\/clienttype?post=46075"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}